Evaluation of adjunctive HPV testing by Hybrid Capture II® in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy

BMC Infectious Diseases

Volumn 3, Issue , 2003, Pages

  Guyot, Andrea ^a   Karim, Shakir ^a   Kyi, May S ^a   Fox, John ^a  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA HYBRID;

ADULT; AGE; ARTICLE; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOLOGY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DNA DETERMINATION; DYSKARYOSIS; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PAPANICOLAOU TEST; PATIENT REFERRAL; PREDICTION; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS IDENTIFICATION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 0346349403     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-3-23     Document Type: Article

References (15)

1. Walboomers MM, Jacobs MV, Manos MM, Bosch FX, Kummer A, Shah KV, Snijders PJF, Peto J, Meier CJ and Munoz N: Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Southern SA and Herrington CS: Molecular events in uterine cervical cancer. Sex Transm Infect 1998, 74:101-109.
3. Governmental Statistical Service: Cervical Screening Programme, England: 2000-2001. Statistical Bulletin 2001.
4. NHSCSP: Guidelines for clinical practice and programme management. NHSCSP publication 1997, 8:12-15.
5. Healthcare Financial Management Association: NHS Finance in the UK. Introductory Guide 52000:56-64.
6. Quest Diagnostics: Outcome by 31.3.01 for women recommended for gynaecological referral where the smear was registered during April-June 2000. DH form KC61 Part C .
7. Colposcopy clinic of West Middlesex University Hospital: Women referred to colposcopy by referral indication. DH form KC65 1.-3. quarter of 2001;Part A .
8. Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason T and Young LS: Natural history of cervical HPV infection in young women: a longitudinal study. Lancet 2001, 357:1831-1836.
9. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T and Soutter P: HPV testing in primary screening of older women. Br J Cancer 1999, :554-558.
10. Wright TC, Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I and Borgatta L et al.: Reflex human papillomavirus deoxyribonucleic testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998, 178:962-966.
11. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT and Gafni A: Comparison of human papillomavirus DNA testing and repeat Papanicolaou testing in women with low-grade cervical cytologic abnormalities: a randomized trial. Can Med Assoc 2000, 163:701-707.
12. Rebello G, Hallam N, Smart G, Farquharson D and McCafferty M: Human papilloma virus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ 2001, 322:893-894.
13. The Atypical quamous cells of undetermined significance/Low-grade squamous intraepithelial lesions Triage Study (ALTS) group: Human papillomavirus testing for triage of women with with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000, 92:397-402.
14. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF and Hiatt RA: Identifying women with cervical neoplasia. JAMA 1999, 28:1605-1610.
15. Shlay JC, Dunn T, Byers T, Baron A and Douglas JM: Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papilloma virus testing in women with atypia on Papanicolaou smear. Obstet Gynecol 2000, 96:410-416.